USP25 and myocardial infarction: TTC/Evan Blue staining assay showed the reduced myocardial infarction area in I/R‐treated USP25oe mice, indicating that cardiomyocyte‐specific USP25 overexpression significantly ameliorated myocardial I/R injury (Figure 8A–C).